ArticleFrontiers in artificial intelligence2024
Artificial intelligence-based framework for early detection of heart disease using enhanced multilayer perceptron.
Article in Frontiers in artificial intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine Learning-Based Ensemble Predictive Model for Cardiovascular Disease Prevention.The International journal of angiology : official publication of the International College of Angiology, Inc · 2026Article
- A modular deep learning architecture for interpretable disease prediction across tabular clinical and biometric datasets.PloS one · 2026Article
- Novel machine learning models for the prediction of acute respiratory distress syndrome after liver transplantation.Frontiers in artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac disease refers to diseases that affect the heart such as coronary artery diseases, arrhythmia and heart defects and is amongst the most difficult health conditions known to humanity. According to the WHO, heart disease is the foremost cause of mortality worldwide, causing an estimated 17.8 million deaths every year it consumes a significant amount of time as well as effort to figure out what is causing this, especially for medical specialists and doctors. Manual methods for detecting cardiac disease are biased and subject to medical specialist variance. In this aspect, machine learning algorithms have proved to be effective and dependable alternatives for detecting and classifying patients who are affected by heart disease. Precise and prompt detection of human heart disease can assist in avoiding heart failure within the initial stages and enhance patient survival. This study proposed a novel Enhanced Multilayer Perceptron (EMLP) framework complemented by data refinement techniques to enhance predictive accuracy. The classification model asses using the CDC cardiac disease dataset and achieved 92% accuracy by surpassing all the traditional methods. The proposed framework demonstrates significant potential for the early detection and prediction of cardiac-related diseases. Experimental results indicate that the Enhanced Multilayer Perceptron (EMLP) model outperformed the other algorithms in terms of accuracy, precision, F1-score, and recall, underscoring its efficacy in cardiac disease detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.